Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Radiol ; 92: 159-165, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28624014

RESUMO

OBJECTIVES: To determine whether mild stage chronic obstructive pulmonary disease (COPD) can be detected on chest radiography without substantial overdiagnosis. METHODS: A retrospective nested case-control study (case:control, 1:1) was performed in 783 patients scheduled for cardiothoracic surgery who underwent both spirometry and a chest radiograph preoperative. Diagnostic accuracy of chest radiography for diagnosing mild COPD was investigated using objective measurements and overall appearance specific for COPD on chest radiography. Inter-observer variability was investigated and variables with a kappa >0.40 as well as baseline characteristics were used to make a diagnostic model which was aimed at achieving a high positive predictive value (PPV). RESULTS: Twenty percent (155/783) had COPD. The PPV of overall appearance specific for COPD alone was low (37-55%). Factors in the diagnostic model were age, type of surgery, gender, distance of the right diaphragm apex to the first rib, retrosternal space, sternodiaphragmatic angle, maximum height right diaphragm (lateral view) and subjective impression of COPD (using both views). The model resulted in a PPV of 100%, negative predictive value (NPV) of 82%, sensitivity of 10% and specificity of 100% with an area under the curve of 0.811. CONCLUSIONS: Detection of mild COPD without substantial overdiagnosis was not feasible on chest radiographs in our cohort.


Assuntos
Doença Pulmonar Obstrutiva Crônica/diagnóstico por imagem , Idoso , Estudos de Casos e Controles , Diafragma/fisiopatologia , Feminino , Volume Expiratório Forçado/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Variações Dependentes do Observador , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Radiografia Torácica/normas , Estudos Retrospectivos , Sensibilidade e Especificidade , Capacidade Vital/fisiologia
2.
J Clin Invest ; 107(2): 225-34, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11160139

RESUMO

LPS-binding protein (LBP) and serum lipoproteins cooperate in reducing the toxic properties of LPS. In the present study, we demonstrate that LBP circulates in association with LDL and VLDL in healthy persons. ApoB was found to account at least in part for the interaction of LBP with LDL and VLDL. Although LBP interacted with purified apoA-I in vitro, no association of LBP with apoA-I or HDL was found in serum. Consistent with the observed association of LBP with LDL and VLDL, these lipoproteins also were demonstrated to be the predominant LPS-binding lipoproteins. Most interestingly, the association of LBP with LDL and VLDL strongly enhanced the capacity of these lipoproteins to bind LPS. Because this function of LBP is of utmost importance during infection, the association of LBP and LPS with lipoproteins was also studied in serum from septic patients. In septic serum containing high LBP levels and a markedly altered lipoprotein spectrum, most of the LBP is associated with LDL and VLDL, although some LBP appeared to circulate free from lipoproteins. Also in this serum, LPS was found to bind predominantly to LDL and VLDL. The observed binding of LBP and LPS to LDL and VLDL, as well as the LBP-dependent incorporation of LPS into these lipoproteins, emphasizes a crucial role for circulating LBP-LDL/VLDL complexes in the scavenging of LPS.


Assuntos
Proteínas de Fase Aguda , Apolipoproteínas B/metabolismo , Proteínas de Transporte/metabolismo , Lipopolissacarídeos/metabolismo , Lipoproteínas LDL/metabolismo , Lipoproteínas VLDL/metabolismo , Glicoproteínas de Membrana , Sepse/sangue , Apolipoproteínas B/sangue , Proteínas de Transporte/sangue , Humanos , Lipopolissacarídeos/sangue , Lipoproteínas LDL/química , Lipoproteínas VLDL/química
3.
J Immunol ; 165(8): 4561-6, 2000 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-11035097

RESUMO

Lipopolysaccharide-binding protein (LBP) is an important modulator of the host's response to endotoxin. In a previous study, we found evidence for the synthesis of LBP by intestinal epithelial cells. In this study, we explored the polarity of LBP secretion by these cells. Polarized monolayers of Caco-2 cells were used as intestinal mucosa model. Cells were stimulated apically or basally with cytokines, and LBP secretion was analyzed. Furthermore, the presence of LBP in intestinal mucus of healthy and endotoxemic mice was studied using a mucus-sampling technique. The constitutive unipolar LBP secretion from the apical cell surface was markedly enhanced when cells were exposed to cytokines at their apical surface. However, bioactive LBP was secreted from both cell surfaces after basolateral stimulation of cells. Cytokines also influenced the secretion of the acute phase proteins serum amyloid A, apoA-I, and apoB from both surfaces of Caco-2 cells. Furthermore, transport of exogenous LBP from the basolateral to the apical cell surface was demonstrated. In line with these in vitro data, the presence of LBP in intestinal mucus was strongly enhanced in mice after a challenge with endotoxin. The results indicate that LBP is present at the mucosal surface of the intestine, a phenomenon for which secretion and transport of LBP by intestinal epithelial cells may be responsible.


Assuntos
Proteínas de Fase Aguda , Proteínas de Transporte/genética , Proteínas de Transporte/metabolismo , Mucosa Intestinal/metabolismo , Lipopolissacarídeos/metabolismo , Glicoproteínas de Membrana , Muco/metabolismo , Animais , Apolipoproteína A-I/genética , Apolipoproteína A-I/metabolismo , Apolipoproteínas/genética , Apolipoproteínas/metabolismo , Apolipoproteínas B/genética , Apolipoproteínas B/metabolismo , Transporte Biológico/genética , Transporte Biológico/imunologia , Células CACO-2/imunologia , Células CACO-2/metabolismo , Membrana Celular/imunologia , Membrana Celular/metabolismo , Polaridade Celular/genética , Polaridade Celular/imunologia , Endotoxemia/imunologia , Endotoxemia/metabolismo , Endotoxinas/farmacologia , Vetores Genéticos/imunologia , Vetores Genéticos/metabolismo , Humanos , Mucosa Intestinal/citologia , Mucosa Intestinal/imunologia , Secreções Intestinais/imunologia , Secreções Intestinais/metabolismo , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Camundongos , Muco/imunologia , Proteína Amiloide A Sérica/genética , Proteína Amiloide A Sérica/metabolismo
4.
J Immunol ; 163(5): 2792-8, 1999 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-10453023

RESUMO

The acute phase proteins LPS binding protein (LBP) and serum amyloid A (SAA) are produced by the liver and are present in the circulation. Both proteins have been shown to participate in the immune response to endotoxins. The intestinal mucosa forms a large surface that is continuously exposed to these microbial products. By secretion of antimicrobial and immunomodulating agents, the intestinal epithelium contributes to the defense against bacteria and their products. The aim of this study was to explore the influence of the inflammatory mediators TNF-alpha, IL-6, and IL-1beta on the release of LBP and SAA by intestinal epithelial cells (IEC). In addition, the induction of LBP and SAA release by cell lines of intestinal epithelial cells and hepatic cells was compared. The data obtained show that in addition to liver cells, IEC also expressed LBP mRNA and released bioactive LBP and SAA upon stimulation. Regulation of LBP and SAA release by IEC and hepatocytes was typical for class 1 acute phase proteins, although differences in regulation between the cell types were observed. Endotoxin did not induce LBP and SAA release. Glucocorticoids were demonstrated to strongly enhance the cytokine-induced release of LBP and SAA by IEC, corresponding to hepatocytes. The data from this study, which imply that human IEC can produce LBP and SAA, suggest a role for these proteins in the local defense mechanism of the gut to endotoxin. Furthermore, the results demonstrate that tissues other than the liver are involved in the acute phase response.


Assuntos
Proteínas de Fase Aguda , Reação de Fase Aguda/metabolismo , Apolipoproteínas/metabolismo , Proteínas de Transporte/metabolismo , Mucosa Intestinal/metabolismo , Lipopolissacarídeos/metabolismo , Glicoproteínas de Membrana , Proteína Amiloide A Sérica/metabolismo , Reação de Fase Aguda/imunologia , Adjuvantes Imunológicos/farmacologia , Apolipoproteínas/biossíntese , Apolipoproteínas/imunologia , Células CACO-2/efeitos dos fármacos , Células CACO-2/imunologia , Células CACO-2/metabolismo , Carcinoma Hepatocelular/metabolismo , Proteínas de Transporte/biossíntese , Proteínas de Transporte/química , Proteínas de Transporte/imunologia , Linhagem Celular , Citocinas/farmacologia , Dexametasona/farmacologia , Endotoxinas/farmacologia , Escherichia coli/imunologia , Humanos , Íleo/metabolismo , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/imunologia , Jejuno/metabolismo , Cinética , Proteína Amiloide A Sérica/biossíntese , Proteína Amiloide A Sérica/imunologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...